Brown, S., Sherratt, D., Hinsley, S., Flanagan, L., Roberts, S., Walker, K., . . . Kaiser, M. (2021). MUKnine OPTIMUM protocol: A screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia. BMJ Open.

Brown, Sarah, et al. "MUKnine OPTIMUM Protocol: A Screening Study to Identify High-risk Patients With Multiple Myeloma Suitable for Novel Treatment Approaches Combined With a Phase II Study Evaluating Optimised Combination of Biological Therapy in Newly Diagnosed High-risk Multiple Myeloma and Plasma Cell Leukaemia." BMJ Open 2021.

Brown, Sarah, et al. "MUKnine OPTIMUM Protocol: A Screening Study to Identify High-risk Patients With Multiple Myeloma Suitable for Novel Treatment Approaches Combined With a Phase II Study Evaluating Optimised Combination of Biological Therapy in Newly Diagnosed High-risk Multiple Myeloma and Plasma Cell Leukaemia." BMJ Open 2021.